Trials / Unknown
UnknownNCT06200376
A Clinical Study of Intraperitoneal T3011 Given as a Single Agent in Patients With Malignant Ascites Induced by Advanced Colorectal Cancer
A Clinical Study of Safety and Efficacy of T3011 Administered Via Intraperitoneal Injection as a Single Agent in Patients With Malignant Ascites Induced by Advanced Colorectal Cancer
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- West China Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, open, single-arm, investigator-initiated clinical study to evaluate the safety and efficacy of intraperitoneal administration of T3011 at different doses in the treatment of malignant ascites induced by advanced colorectal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | T3011 | T3011 will be administered intraperitoneally twice a week. |
Timeline
- Start date
- 2023-09-28
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
- First posted
- 2024-01-11
- Last updated
- 2024-01-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06200376. Inclusion in this directory is not an endorsement.